Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
life sciences
national blog main
national top stories
san diego blog main
6
×
san diego top stories
boston blog main
boston top stories
new york blog main
new york top stories
clinical trials
drugs
san francisco blog main
san francisco top stories
akcea therapeutics
alnylam pharmaceuticals
biotech
boston
hereditary transthyretin amyloidosis
inotersen
patisiran
tafamidis
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
onpattro
pfizer
raleigh-durham blog main
raleigh-durham top stories
rna interference
seattle blog main
seattle top stories
texas blog main
texas top stories
vyndaqel
What
fda
6
×
medicine
6
×
drug
alnylam
approved
cancer
cells
loss
patients
rna
rnai
time
uses
afternoon
ago
alnylam’s
approve
approves
awaits
biological
cleared
clinical
company
cosmeceutical
crossed
decades
decision
deeper
diego’s
discovered
dna
eisai
ema
employ
europe
female
fingerprint
fingers
flags
follows
Language
unset
Current search:
medicine
×
" san diego blog main "
×
fda
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing